Bilaketaren emaitzak - Andreas Schwarting
- Erakusten 1 - 20 emaitzak -- 35
- Go to Next Page
-
1
Role of Human Leukocyte Antigens (HLA) in Autoimmune Diseases nork Gergely Bodis, Victoria Toth, Andreas Schwarting
Argitaratua 2018Revisão -
2
Systemic Lupus Erythematosus (SLE) Therapy: The Old and the New nork Fabio Basta, Federica Fasola, Konstantinos Triantafyllias, Andreas Schwarting
Argitaratua 2020Revisão -
3
-
4
-
5
-
6
-
7
Colony-Stimulating Factor-1 nork Julia Menke, Kerstin Amann, Lorenzo Cavagna, Maria Blettner, Arndt Weinmann, Andreas Schwarting, Vicki Rubin Kelley
Argitaratua 2014Artigo -
8
Comparative analysis of procoagulatory activity of haemodialysis, haemofiltration and haemodiafiltration with a polysulfone membrane (APS) and with different modes of enoxaparin an... nork Reinhard Klingel, Marion Schaefer, Andreas Schwarting, Frido Himmelsbach, U. Altes, Ingrid Uhlenbusch‐Körwer, G. Hafner
Argitaratua 2003Artigo -
9
-
10
OP0048 Outcomes in Systemic Lupus Erythematous (SLE) Patients Treated with Belimumab in Clinical Practice Settings: Results from the Observe Study in Germany nork Andreas Schwarting, V. Koscielny, Heike Carnarius, Constanze Cholmakow-Bodechtel, Tobias Alexander, Christoph Fiehn, Christof Specker, Marc Schmalzing
Argitaratua 2014Artigo -
11
Interleukin 6 (IL-6) Deficiency Delays Lupus Nephritis in MRL-<i>Fas<sup>lpr</sup></i>Mice: The IL-6 Pathway as a New Therapeutic Target in Treatment of Autoimmune Kidney Disease i... nork Hannes Cash, Manfred Relle, Julia Menke, Christoph Brochhausen, Simon A. Jones, Nicholas Topley, Peter R. Galle, Andreas Schwarting
Argitaratua 2009Artigo -
12
Real-World Effectiveness of Belimumab in the Treatment of Systemic Lupus Erythematosus: Pooled Analysis of Multi-Country Data from the OBSErve Studies nork Christopher Collins, Josefina Cortés-Hernández, Mercedes García, Johannes von Kempis, Andreas Schwarting, Zahi Touma, Milena Kurtinecz, Kerry Gairy
Argitaratua 2020Artigo -
13
-
14
-
15
Constitutive knockout of interleukin-6 ameliorates memory deficits and entorhinal astrocytosis in the MRL/lpr mouse model of neuropsychiatric lupus nork Joshua Reynolds, Michelle Huang, Yaxi Li, Myriam Meineck, Tamara Moeckel, Julia Weinmann‐Menke, Chandra Mohan, Andreas Schwarting, Chaim Putterman
Argitaratua 2024Artigo -
16
-
17
Efficacy and Safety of Selexipag in Adults With Raynaud's Phenomenon Secondary to Systemic Sclerosis nork Christopher P. Denton, É. Hachulla, Gabriela Riemekasten, Andreas Schwarting, Jean‐Marie Frenoux, Aline Frey, Franck‐Olivier Le Brun, Ariane L. Herrick
Argitaratua 2017Artigo -
18
First Real-World Insights into Belimumab Use and Outcomes in Routine Clinical Care of Systemic Lupus Erythematosus in Germany: Results from the OBSErve Germany Study nork Andreas Schwarting, Johann O. Schroeder, Tobias Alexander, Marc Schmalzing, Christoph Fiehn, Christof Specker, Alessandra F. Perna, Constanze Cholmakow-Bodechtel, V. Koscielny, Heike Carnarius
Argitaratua 2016Artigo -
19
Ocular markers of microangiopathy and their possible association with cardiovascular risk in patients with systemic inflammatory rheumatic diseases: a systematic review nork Barbara Sturm, Aimin Zang, Julia Stingl, Rebecca Hasseli-Fräbel, Antonis Fanouriakis, Andreas Schwarting, Christian Geber, Julia Weinmann‐Menke, Mohammad Al‐Haddad, Konstantinos Triantafyllias
Argitaratua 2025Revisão -
20
CSF-1 signals directly to renal tubular epithelial cells to mediate repair in mice nork Julia Menke, Yasunori Iwata, Whitney Rabacal, Ranu Basu, Yee-Guide Yeung, Benjamin D. Humphreys, Takashi Wada, Andreas Schwarting, E. Richard Stanley, Vicki Rubin Kelley
Argitaratua 2009Artigo
Bilaketa egiteko lanabesak:
Antzeko gaiak
Medicine
Internal medicine
Immunology
Disease
Antibody
Pathology
Systemic lupus erythematosus
B cell
B-cell activating factor
Belimumab
Gastroenterology
Alternative medicine
Biology
Endocrinology
Environmental health
Kidney
Population
Chemistry
Lupus erythematosus
Placebo
Autoimmune disease
Biochemistry
Inflammation
Interstitial lung disease
Lung
Lupus nephritis
Nephritis
Randomized controlled trial
Adverse effect
Antisynthetase syndrome